AU591462B2 - New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them - Google Patents

New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them

Info

Publication number
AU591462B2
AU591462B2 AU47672/85A AU4767285A AU591462B2 AU 591462 B2 AU591462 B2 AU 591462B2 AU 47672/85 A AU47672/85 A AU 47672/85A AU 4767285 A AU4767285 A AU 4767285A AU 591462 B2 AU591462 B2 AU 591462B2
Authority
AU
Australia
Prior art keywords
compound
phenoxy
adenosine
hydroxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU47672/85A
Other languages
English (en)
Other versions
AU4767285A (en
Inventor
Silvano Casadio
Duccio Favara
Amedeo Omodei-Sale
Ezio Panto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierrel SpA
Original Assignee
Pierrel SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel SpA filed Critical Pierrel SpA
Publication of AU4767285A publication Critical patent/AU4767285A/en
Application granted granted Critical
Publication of AU591462B2 publication Critical patent/AU591462B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU47672/85A 1984-09-20 1985-09-19 New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them Ceased AU591462B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22739/84 1984-09-20
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Publications (2)

Publication Number Publication Date
AU4767285A AU4767285A (en) 1986-03-27
AU591462B2 true AU591462B2 (en) 1989-12-07

Family

ID=11199882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47672/85A Ceased AU591462B2 (en) 1984-09-20 1985-09-19 New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4774325A (enExample)
EP (1) EP0175325B1 (enExample)
JP (1) JPS61112077A (enExample)
AT (1) ATE41430T1 (enExample)
AU (1) AU591462B2 (enExample)
CA (1) CA1268175A (enExample)
DE (1) DE3568783D1 (enExample)
DK (1) DK167318B1 (enExample)
ES (1) ES8701773A1 (enExample)
GR (1) GR852261B (enExample)
IT (1) IT1196261B (enExample)
NZ (1) NZ213550A (enExample)
PT (1) PT81045B (enExample)
ZA (1) ZA857075B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
EP0691968B1 (en) * 1993-03-30 1997-07-16 Sanofi Acyclic nucleoside analogs and oligonucleotide sequences containing them
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
CA2440809A1 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP1440072A4 (en) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
JP3929949B2 (ja) * 2003-08-08 2007-06-13 独立行政法人科学技術振興機構 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法
NZ546611A (en) 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
BRPI0609509A2 (pt) * 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
US20070105874A1 (en) * 2005-09-23 2007-05-10 Conforma Therapeutics Corporation Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 Inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE111312C (enExample) * 1897-12-16
US2819260A (en) * 1953-06-04 1958-01-07 Petrolite Corp Process for preparing oxyalkylated derivatives
US3391196A (en) * 1965-08-16 1968-07-02 Wyandotte Chemicals Corp High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols
US3712885A (en) * 1968-09-10 1973-01-23 G Weimann Purine-ribofuranoside-3',5'-cyclophosphates and process for their preparation
JPS5133799B2 (enExample) * 1973-06-14 1976-09-21
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
DE2631046A1 (de) * 1975-07-15 1977-01-20 Snam Progetti Adeninderivate und verfahren zu deren herstellung
SU883056A1 (ru) * 1980-03-26 1981-11-23 Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3169373D1 (en) * 1980-08-06 1985-04-25 Shell Int Research Process for the manufacture of polyether polyols and their use for preparing polyurethanes
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体

Also Published As

Publication number Publication date
ES547856A0 (es) 1987-01-01
IT8422739A1 (it) 1986-03-20
JPH0569109B2 (enExample) 1993-09-30
DK426185A (da) 1986-03-21
EP0175325B1 (en) 1989-03-15
DK167318B1 (da) 1993-10-11
PT81045B (pt) 1987-09-18
ES8701773A1 (es) 1987-01-01
DK426185D0 (da) 1985-09-19
US4774325A (en) 1988-09-27
ATE41430T1 (de) 1989-04-15
DE3568783D1 (en) 1989-04-20
EP0175325A3 (en) 1987-02-04
IT1196261B (it) 1988-11-16
IT8422739A0 (it) 1984-09-20
JPS61112077A (ja) 1986-05-30
PT81045A (en) 1985-09-01
GR852261B (enExample) 1986-01-17
CA1268175A (en) 1990-04-24
EP0175325A2 (en) 1986-03-26
ZA857075B (en) 1986-06-25
AU4767285A (en) 1986-03-27
NZ213550A (en) 1989-06-28

Similar Documents

Publication Publication Date Title
AU4767285A (en) New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them
AU573540B2 (en) 6-hydrogen purine derivatives
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
DE3264465D1 (en) 7-beta-d-arabinofuranosyl-7h-pyrrolo(2,3-d)pyrimidine-4-amine 5'-phosphate compounds useful as antiviral agents, pharmaceutical compositions containing the compounds, and processes for producing the compounds
RO86647B (ro) Procedeu pentru prepararea unor derivati de 4''-epieritromicina
AU568274B2 (en) Process for preparation of 4-hydroxy-2-oxo-1-pyrrolidine derivatives
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
JPS5746999A (en) Beta-d-arabinofuranosylimidazo(4,5-c)pyridine compound and manufacture
EP0158340A3 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
HK27689A (en) Sialic acid derivatives and process for the preparation thereof
ZA855594B (en) Naphthyl analogs of mevalonolactone and derivatives thereof,processes for their production and their use
AU557360B2 (en) Substituted ethenyl derivatives of 1h-pyrazolo (1,5-alpha) pyrimidine
DE3160133D1 (en) 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
AU1226588A (en) A process for the preparation of 9-(hydroxyalkyl)-hypoxanthines
JPS6461494A (en) Production of 5'-0-acyl-5-fluorouridine derivative
EP0367036A3 (en) Substituted 3-aminosydnonimines, process for their preparation and their use
IE872998L (en) 4-hydroxy-4-(substituted alkenyl)- cyclohexanecarboxylic¹acids
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation
ES8506679A2 (es) Mejoras en el objeto de la patente de invencion n 514.340 que se refiere a: procedimiento de obtencion de nuevos derivados de piperazina
CA1266642C (en) MONOSACCHARIDE COMPOUNDS WITH IMMUNOSTIMULATING ACTION
JPS5432469A (en) Novel imidazoline riboside derivatives and their preparation
YU39387A (en) Process for preparation of derivatives 1,3 diazolyle-2-propanol